Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Amplicon sequencing demonstrates comparable follicular mycobiomes in patients with hidradenitis suppurativa compared with healthy controls

Publikation: Bidrag til tidsskriftLetterpeer review

DOI

Vis graf over relationer
OriginalsprogEngelsk
TidsskriftJournal of the European Academy of Dermatology and Venereology
Vol/bind36
Udgave nummer7
Sider (fra-til)e580-e583
ISSN0926-9959
DOI
StatusUdgivet - jul. 2022

Bibliografisk note

Funding Information:
Dr. Ring has received research funding from the Kgl Hofbundtmager Aage Bang Foundation and honoraria as speaker from Leo Pharma. Dr. Thorsen. None. Ms. Bay None. Prof. TB none. Dr. KF None. Ms. AI None. Dr. Frew has conducted advisory work for Janssen, Boehringer‐Ingelheim, Pfizer, Kyowa Kirin, LEO Pharma, Regeneron, Chemocentryx, Abbvie and UCB, participated in trials for Pfizer, UCB, Boehringer‐Ingelheim, Eli Lilly, CSL, Janssen and received research support from Ortho Dermatologics and Sun Pharma. Mr. HV None. Dr. Thomsen has been a speaker and/or served on advisory boards for AbbVie, Almirall, Eli Lilly, Janssen, LEO Pharma, Novartis, Pfizer, Sanofi and UCB, and has received research support from AbbVie, Janssen, LEO Pharma, Novartis, Sanofi and UCB. Dr. Egeberg has received research funding from Pfizer, Eli Lilly, Novartis, Bristol‐Myers Squibb, AbbVie, Janssen Pharmaceuticals, the Danish National Psoriasis Foundation, the Simon Spies Foundation, and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as consultant and/or speaker from AbbVie, Almirall, Leo Pharma, Zuellig Pharma Ltd., Galápagos NV, Sun Pharmaceuticals, Samsung Bioepis Co., Ltd., Pfizer, Eli Lilly and Company, Novartis, Galderma, Dermavant, UCB, Mylan, Bristol‐Myers Squibb, and Janssen Pharmaceuticals. Dr. DMS has received honoraria from Novozymes and Leo Pharma. Dr. GJ has received research grants from Abbvie, Leo Foundation, Afyx, InflaRx, Janssen, Novartis, UCB, Regeneron, Sanofi, Union Therapeutics and consulting fees from Coloplast, Chemocentryx, Leopharma, Incyte, Kymera and VielaBio.

ID: 79246531